Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis

FF Rahaghi, RP Baughman… - European …, 2020 - publications.ersnet.org
Pulmonary sarcoidosis presents substantial management challenges, with limited evidence
on effective therapies and phenotypes. In the absence of definitive evidence, expert …

[HTML][HTML] Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study

AC Schutt, WM Bullington, MA Judson - Respiratory medicine, 2010 - Elsevier
BACKGROUND: Most issues concerning pharmacotherapy of pulmonary sarcoidosis have
not been resolved in clinical trials. The objective was to survey sarcoidosis experts …

ERS clinical practice guidelines on treatment of sarcoidosis

RP Baughman, D Valeyre, P Korsten… - European …, 2021 - Eur Respiratory Soc
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

Corticosteroids for pulmonary sarcoidosis

NS Paramothayan, TJ Lasserson… - Cochrane Database of …, 2005 - cochranelibrary.com
Background Pulmonary sarcoidosis is a common condition with an unpredictable course.
Oral (OCS) or inhaled steroids (ICS) are widely used in its treatment, but there is no …

Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches

ON Obi, LA Saketkoo, AM Russell… - Frontiers in …, 2022 - frontiersin.org
Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …

Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis

NS Paramothayan, TJ Lasserson… - Cochrane Database …, 1996 - cochranelibrary.com
Background Immunosuppressive and cytotoxic agents have been used as both an
alternative to oral corticosteroids, and as a means of maintaining a low dose of steroids in …

Established and experimental medical therapy of pulmonary sarcoidosis

RP Baughman, H Nunes, NJ Sweiss… - European Respiratory …, 2013 - Eur Respiratory Soc
The treatment options for pulmonary sarcoidosis have increased over the past 10 years. As
new treatments have been introduced, the best way to assess and compare treatments …

BTS Clinical Statement on pulmonary sarcoidosis

M Thillai, CP Atkins, A Crawshaw, SP Hart, LP Ho… - Thorax, 2021 - thorax.bmj.com
This British Thoracic Society (BTS) Clinical Statement addresses the diagnosis, evaluation
and management of pulmonary sarcoidosis, with each section summarised with key clinical …

Corticosteroid therapy in pulmonary sarcoidosis: a systematic review

S Paramothayan, PW Jones - Jama, 2002 - jamanetwork.com
ContextCorticosteroids are used in pulmonary sarcoidosis to reduce symptoms and
minimize long-term damage. Spontaneous recovery is a common feature. Both the decision …

[PDF][PDF] Endpoints for clinical trials of sarcoidosis

RP Baughman, M Drent, DA Culver… - … Vasc Diffuse Lung …, 2012 - researchgate.net
Over the past few years an increasing number of prospective controlled sarcoidosis
treatment trials have been completed. Unfortunately, these studies utilize different endpoints …